BIOCON INC (EIN 223619257) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1998

Legal Domicile

Principal Officer

JOSEPH A YACCARINO

Phone

7326610202

Tax Period

2024-01-01 to 2024-12-31

BIOCON INC, founded in 1998, is a community nonprofit in the Health Care sector that reported $4.6M in total revenue in fiscal year 2024. Revenue surged 21% from the prior year, signaling strong growth momentum. Expenses of $4.1M left a modest 11% surplus.

Mission

BIOCON INC. (BIO) IS THE PARENT HOLDING COMPANY FOR THE MUSCULOSKELETAL TRANSPLANT FOUNDATION.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $0

Investment Income $0

Other Revenue $4,649,455

TOTAL REVENUE $4,649,455

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $2,115,366

Other Expenses $4,130,474

TOTAL EXPENSES $4,130,474

Year-over-Year Comparison

	2024	2023	Change
Revenue	$4,649,455	$3,848,762	+0.2%
Expenses	$4,130,474	$3,196,702	+0.3%
Net Income	$518,981	$652,060	-0.2%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$2,190,085

Total Directors

$192,500

Key Employees

Highest Compensated

reported

Name	Title	Role	Reportable Comp	Other Comp	Total
WILLIAM W TOMFORD MD	DIRECTOR	Director	$0	$0	$75,000
DONALD HACKBARTH MD	DIRECTOR	Director	$0	$0	$35,000
JOSEPH D ZUCKERMAN MD	DIRECTOR	Director	$0	$0	$30,000
SYMERIA T HUDSON	DIRECTOR	Director	$0	$0	$0
JOSEPH A BUCKWALTER MD	DIRECTOR	Director	$0	$0	$27,500
SHARON GABRIELSON	DIRECTOR	Director	$0	$0	$25,000
ALLAN GROSS MD	NON-VOTING DIRECTOR	Director	$0	$0	$0
GERALD FINERMAN MD	NON-VOTING DIRECTOR	Director	$0	$0	$0
JOSEPH A YACCARINO	PRESIDENT / CEO	Officer	$0	$56,874	$958,758
MICHAEL J KAWAS	TREASURER / CFO	Officer	$0	$36,365	$697,388
JENNIFER BIRMINGHAM	SECRETARY / GENERAL COUNSEL	Officer	$0	$56,656	$533,939

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$4,649,455	$4,130,474	$30,182,299	$518,981
2023	$3,848,762	$3,196,702	$30,050,664	$652,060
2022	$3,214,643	$2,370,753	$16,971,976	$843,890
2021	$3,342,644	$2,564,076	$16,726,556	$778,568
2020	$3,223,664	$2,433,895	$16,802,691	$789,769
2019	$3,431,997	$2,699,107	$16,108,259	$732,890
2018	$3,469,939	$3,161,133	$18,191,937	$308,806

BIOCON INC